BETHESDA, Md. - The National Institutes of Health announced on Wednesday that it has begun an observational study to evaluate how pregnant or postpartum recipients react to COVID-19 vaccines.
For the study, researchers will measure the development and durability of antibodies to fight COVID-19 in people who get vaccinated during pregnancy as well as vaccinated individuals during the first two postpartum months.
Researchers say they also hope to understand how the antibodies of the COVID-19 vaccine can impact unborn children. The study is being referred to as MOMI-VAX and is sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), a medical wing of the NIH. "Tens of thousands of pregnant and breastfeeding.